Omesdafexor

N/A

Report date: 2025/12/08 17:14:06
NME

Base Information

Drug NameOmesdafexor
Drug Alias NameMET-642FXR-314
ClassificationBiologics
Mechanisms of ActionBile acid receptor FXR agonists
TargetsBile acid receptor FXR
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseInflammatory Bowel DiseasesColitis, Ulcerative +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesMetacrine
China Registration ClassN/A

Develop Information

Active CompaniesOrganovo Holdings IncMetacrine IncEli Lilly And Company +[5] 
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseInflammatory Bowel DiseasesColitis, Ulcerative +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipedia